J Bladé

574 total citations
15 papers, 221 citations indexed

About

J Bladé is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, J Bladé has authored 15 papers receiving a total of 221 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 6 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in J Bladé's work include Multiple Myeloma Research and Treatments (7 papers), Protein Degradation and Inhibitors (4 papers) and Acute Myeloid Leukemia Research (2 papers). J Bladé is often cited by papers focused on Multiple Myeloma Research and Treatments (7 papers), Protein Degradation and Inhibitors (4 papers) and Acute Myeloid Leukemia Research (2 papers). J Bladé collaborates with scholars based in Spain, Italy and Poland. J Bladé's co-authors include Laura Rosiñol, Jesús F. San Miguel, Mario Boccadoro, Pieter Sonneveld, Jordi Yagüe, Montserrat Rovira, Xavier Filella, Natalia Tovar, Carlos Fernández de Larrea and Laura Rosiñol and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Haematologica.

In The Last Decade

J Bladé

13 papers receiving 215 citations

Peers

J Bladé
Ilaria Scortechini Italy
Zoé Van de Wyngaert France
Maria Carmen Martorelli Italy
Kalman Filanovsky Israel
Dixil Francis United States
Lars‐Olof Mügge Germany
Sigrún Þorsteinsdóttir Denmark
Bonnie Jenkins United States
Katarina Uttervall Sweden
Jessie Bourcier France
Ilaria Scortechini Italy
J Bladé
Citations per year, relative to J Bladé J Bladé (= 1×) peers Ilaria Scortechini

Countries citing papers authored by J Bladé

Since Specialization
Citations

This map shows the geographic impact of J Bladé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Bladé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Bladé more than expected).

Fields of papers citing papers by J Bladé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Bladé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Bladé. The network helps show where J Bladé may publish in the future.

Co-authorship network of co-authors of J Bladé

This figure shows the co-authorship network connecting the top 25 collaborators of J Bladé. A scholar is included among the top collaborators of J Bladé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Bladé. J Bladé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Tovar, Natalia, Carlos Fernández de Larrea, Juan I. Aróstegui, et al.. (2013). Natural history and prognostic impact of oligoclonal humoral response in patients with multiple myeloma after autologous stem cell transplantation: long-term results from a single institution. Haematologica. 98(7). 1142–1146. 39 indexed citations
3.
Kropff, Martin, Jens Hillengaß, Tadeusz Robak, et al.. (2011). Thalidomide versus dexamethasone for the treatment of relapsed and/or refractory multiple myeloma: results from OPTIMUM, a randomized trial. Haematologica. 97(5). 784–791. 43 indexed citations
4.
Palumbo, Antonio, J Bladé, Mario Boccadoro, et al.. (2011). How to Manage Neutropenia in Multiple Myeloma. Clinical Lymphoma Myeloma & Leukemia. 12(1). 5–11. 40 indexed citations
5.
Reece, DE, Ute Hegenbart, Vaishali Sanchorawala, et al.. (2010). Weekly and twice-weekly bortezomib in AL amyloidosis: Results of a phase II study.. Journal of Clinical Oncology. 28(15_suppl). 8023–8023. 1 indexed citations
6.
Bladé, J & Laura Rosiñol. (2009). Changing paradigms in the treatment of multiple myeloma. Haematologica. 94(2). 163–166. 14 indexed citations
7.
8.
Miguel, Jesús F. San, Paul G. Richardson, Pieter Sonneveld, et al.. (2005). Frequency, Characteristics, and Reversibility of Peripheral Neuropathy (PN) in the APEX Trial.. Blood. 106(11). 366–366. 35 indexed citations
9.
Bladé, J, et al.. (1998). [Contribution of magnetic resonance to the differential diagnosis of a collapsed vertebra in a patient with multiple myeloma].. PubMed. 43(1). 77–81.
10.
Montserrat, E, J Garcı́a-Conde, Núria Viñolas, et al.. (1996). CHOP vs. ProMACE‐CytaBOM in the treatment of aggressive non‐Hodgkin's lymphomas: long‐term results of a multicenter randomized trial. European Journal Of Haematology. 57(5). 377–383. 28 indexed citations
11.
Saló, Joan, Josep‐María Ribera, J Bladé, et al.. (1990). [Sepsis caused by Candida parapsilosis. Joint and lung involvement in 2 patients with acute leukemia].. PubMed. 94(2). 58–60. 2 indexed citations
12.
Grañena, A, C Rozmán, Enric Carreras, et al.. (1985). [Bone marrow transplantation in acute leukemia: results in a series of 51 consecutive patients prepared with cyclophosphamide and total body irradiation].. PubMed. 85(12). 479–85. 2 indexed citations
13.
Gardella, Santiago, et al.. (1984). Acute Myeloblastic Leukaemia Presenting with Superior Vena cava Syndrome Due to Mediastinal Mass. Acta Haematologica. 71(3). 174–177. 9 indexed citations
14.
Ribera, Josep‐María, J Bladé, Guadalupe Ercilla, Evarist Feliú, & C Rozmán. (1984). [Idiopathic thrombocytopenic purpura following recovery from a benzol-induced bone marrow aplasia].. PubMed. 29(2). 224–5.
15.
Ribera, Josep‐María, et al.. (1983). [Osteolytic lesions in idiopathic myelofibrosis: presentation of 2 cases].. PubMed. 81(19). 861–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ilaria Scortechini Breakdown of academic impact, for papers by Zoé Van de Wyngaert Breakdown of academic impact, for papers by Maria Carmen Martorelli Breakdown of academic impact, for papers by Kalman Filanovsky Breakdown of academic impact, for papers by Dixil Francis Breakdown of academic impact, for papers by Lars‐Olof Mügge Breakdown of academic impact, for papers by Sigrún Þorsteinsdóttir Breakdown of academic impact, for papers by Bonnie Jenkins Breakdown of academic impact, for papers by Katarina Uttervall Breakdown of academic impact, for papers by Jessie Bourcier
Rankless by CCL
2026